支气管动脉灌注化疗联合栓塞术对非小细胞肺癌患者的影响研究  

The Effect of Bronchial Artery Infusion Chemotherapy Combined with Embolization on Non-small Cell Lung Cancer Patients

作　　者：张涛 ZHANG Tao(The Affiliated Baiyun Hospital of Guizhou Medical University,Guiyang,Guizhou 550000)

机构地区：[1]贵州医科大学附属白云医院,贵州贵阳550000

出　　处：《科技与健康》2023年第4期29-32,共4页Technology and Health

摘　　要：分析了采用支气管动脉灌注化疗联合栓塞术治疗非小细胞肺癌的应用价值。选取贵州医科大学附属白云医院2019年1月—2019年12月收治的90例非小细胞肺癌患者为研究对象,分为对比组和研究组。对比组(n=45)接受支气管动脉灌注治疗,研究组(n=45)在对比组基础上联合应用栓塞术。观察两组患者的临床治疗总有效率、并发症发生率、不良反应情况。患者接受临床远期疗效的对比,包括两组患者1、2、3年的生存率比较分析,同时比较两组的血清肿瘤标志物、血清炎性因子、T淋巴细胞亚群比较。不仅如此,还需要将两组患者的临床治疗总依从率进行对比分析。研究发现,支气管动脉灌注化疗联合栓塞术在非小细胞肺癌患者中的应用,实现了患者治疗总有效率的提升,并且有效降低了患者并发症发生率与不良反应问题的出现,患者的生存率得到了保证,血清炎性因子改善明显,T淋巴细胞亚群显著提升,对于患者治疗总依从率提升也有一定的促进意义。Analyzed the application value of bronchial artery infusion chemotherapy combined with embolization in the treatment of non-small cell lung cancer.We selected 90 patients with non-small cell lung cancer admitted to The Affiliated Baiyun Hospital of Guizhou Medical University from January 2019 to December 2019 as the study subjects.The control group(n=45)received bronchial artery infusion therapy,while the study group(n=45)used embolization combined with the control group.Observe the total clinical treatment effi ciency,incidence of complications,and adverse reactions of the two groups of patients.Comparison of long-term clinical effi cacy among patients,including analysis of survival rates at 1,2,and 3 years between two groups of patients,as well as comparison of serum tumor markers,infl ammatory factors,and T lymphocyte subsets between the two groups.Not only that,it is also necessary to compare and analyze the total compliance rate of clinical treatment between the two groups of patients.Research has found that the application of bronchial artery infusion chemotherapy combined with embolization in non-small cell lung cancer patients has achieved an improvement in the overall treatment effi ciency of patients,and effectively reduced the incidence of complications and adverse reactions in patients.The survival rate of patients has been guaranteed,serum infl ammatory factors have been signifi cantly improved,and T lymphocyte subsets have been signifi cantly increased,which also has a certain promoting signifi cance for the overall treatment compliance rate of patients.

关 键 词：支气管动脉灌注化疗 栓塞术 非小细胞肺癌 

分 类 号：R734.2[医药卫生—肿瘤]